Cequent Pharmaceutials Inc., an RNA interference delivery start-up, has raised $6 million in a Series A financing round that could grow to a total of $12 million, the company told VentureWire.
Cequent Pharmaceutials Inc., an RNA interference delivery start-up, has raised $6 million in a Series A financing round that could grow to a total of $12 million, the company told VentureWire.
